DAVID GRANOVSKY

U.S. court rules against Obama’s stem cell policy | Reuters

In STEM CELLS IN THE NEWS on August 23, 2010 at 9:50 pm

A U.S. court ruled in favor of a law suit filed in June against the National Institutes of Health by researchers.   The preliminary injunction on Monday stops federal funding of human embryonic stem cell research under the position that “human embryonic stem cell research involved the destruction of human embryos.”  Christian groups also opposed to embryo research argued the NIH policy violated U.S. law and took funds from researchers seeking to work with adult stem cells.

While this ruling is based on moral issues and not scientific issues, there is a preponderance of evidence that scientifically, embryonic stem cells for treatment may prove to be a dead end for at least 20-50 years and adult stem cells are already proven safe and effective for treating over 130+ diseases in humans.  For more information on why adult stem cells are scientifically better suited for treating humans than embryonic stem cells, read these articles:

U.S. court rules against Obama’s stem cell policy

A microscopic view shows smooth muscle cells derived from human  embryonic stem cells showing the nuclei (blue) and proteins of the  cytoskeleton (green) in this handout photo released to Reuters by the  California Institute for Regenerative Medicine, March 9, 2009.  REUTERS/Alexey Terskikh/Burnham Institute for Medical  Research/California Institute for Regenerative Medicine/Handout

WASHINGTON | Mon Aug 23, 2010 6:22pm EDT

WASHINGTON (Reuters) – A U.S. district court issued a preliminary injunction on Monday stopping federal funding of human embryonic stem cell research, in a slap to the Obama administration’s new guidelines on the sensitive issue.

The court ruled in favor of a suit filed in June by researchers who said human embryonic stem cell research involved the destruction of human embryos.

Judge Royce Lamberth granted the injunction after finding the lawsuit would likely succeed because the guidelines violated law banning the use of federal funds to destroy human embryos.

“(Embryonic stem cell) research is clearly research in which an embryo is destroyed,” Lamberth wrote in a 15-page ruling. The Obama administration could appeal his decision or try to rewrite the guidelines to comply with U.S. law.

The suit against the National Institutes of Health, backed by some Christian groups opposed to embryo research, argued the NIH policy violated U.S. law and took funds from researchers seeking to work with adult stem cells.

The U.S. Department of Justice, White House and NIH had no immediate comment.

Key to the case is the so-called Dickey-Wicker Amendment, which Congress adds to budget legislation every year. It bans the use of federal funds to destroy human embryos.

That was not an issue for the NIH until the discovery of human embryonic stem cells in 1998. In 2001, then-President George W. Bush said he could only allow federal research money to pay for work done using a few batches, or lines, of the cells.

Many stem cell researchers objected, saying they could not do work needed to fulfill the promise of the powerful cells, which can give rise to all the tissues and cells in the human body. Privately funded researchers could do as they pleased, but federal funding is the cornerstone of such basic biological research.

NEW POLICY

As one of his first acts after taking office, Obama overturned that decision and the NIH set up a careful process for deciding which batches of human embryonic stem cells could be used by federally funded researchers.

The new guidelines do not allow the use of federal dollars to create the stem cells but do allow researchers to work with them if they are made by another lab.

Dr. James Sherley of Boston Biomedical Research Institute and Theresa Deisher of Washington-based AVM Biotechnology, who both work with adult stem cells, filed the original suit saying the guidelines would harm their work by increasing competition for limited federal funding. They both oppose the use of human embryonic stem cells.

Sherley was not immediately available for comment.

“There is no after-the-fact remedy for this injury because the Court cannot compensate plaintiffs for their lost opportunity to receive funds,” Lamberth wrote.

He found that the injunction would not seriously harm researchers who focus on human embryonic stem cells because it would preserve the status quo and not interfere with their ability to get private funding.

With the preliminary injunction in place, the two sides will likely present arguments and case history to the judge over whether the guidelines can be permanently blocked or be allowed to go into effect.

(Editing by Peter Cooney)

via U.S. court rules against Obama’s stem cell policy | Reuters.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: